Cancer Management and Research
Volume 13, 2021 - Issue
Open access
86
Views
2
CrossRef citations to date
0
Altmetric
Original Research
The Presence of Genomic Instability in Cerebrospinal Fluid in Patients with Meningeal Metastasis
Peng Wang1 Department of Neuro-Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of China;2 Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, 300060, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0003-0509-1717
, https://orcid.org/0000-0003-0509-1717
Henghui Zhang3 Genecast Biotechnology Co., Ltd, Wuxi, 214000, People’s Republic of China
, Peng Chen3 Genecast Biotechnology Co., Ltd, Wuxi, 214000, People’s Republic of China
, Zengfeng Sun1 Department of Neuro-Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of China;2 Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, 300060, People’s Republic of China
, Zhen Zhang1 Department of Neuro-Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of China;2 Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, 300060, People’s Republic of China
, Qiang Yin1 Department of Neuro-Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of China;2 Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, 300060, People’s Republic of China
, Huaibo Sun3 Genecast Biotechnology Co., Ltd, Wuxi, 214000, People’s Republic of China
& Jinpu Yu2 Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, 300060, People’s Republic of China;4 Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Tianjin, 300060, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-5982-2266
show allhttps://orcid.org/0000-0002-5982-2266
Pages 4853-4863
|
Published online: 21 Jun 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.